|
Re: FDA busts Merck's Keytruda in triple-negative breast cancer with a CRL — not unexpected given its disastrous adcomm
|
1
|
Zenith Epigenetics
|
Mar 30, 2021 04:41PM
|
|
Re: fear stops us from moving forward....
|
2
|
Resverlogix Corp.
|
Sep 17, 2019 07:56PM
|
|
Re: Fiercemarkets article
|
4
|
Resverlogix Corp.
|
Mar 23, 2021 02:00PM
|
|
Re: Filled 1,000 of 1,000 at $2.60
|
|
Resverlogix Corp.
|
Sep 20, 2019 12:38PM
|
|
Re: Finance
|
7
|
Resverlogix Corp.
|
Feb 11, 2021 11:17AM
|
|
Re: Finance
|
5
|
Resverlogix Corp.
|
Feb 06, 2021 05:06PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
Feb 06, 2021 05:42PM
|
|
Re: Finance
|
7
|
Resverlogix Corp.
|
May 29, 2020 10:28AM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
Aug 06, 2020 01:40PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
Aug 06, 2020 02:31PM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
Aug 09, 2020 10:10PM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Feb 10, 2021 05:05PM
|
|
Re: Finance
|
5
|
Resverlogix Corp.
|
Mar 29, 2020 03:55PM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
May 25, 2020 01:06PM
|
|
Re: Finance
|
5
|
Resverlogix Corp.
|
Feb 22, 2021 10:40AM
|
|
Re: Financial Future
|
2
|
Resverlogix Corp.
|
May 13, 2019 01:28PM
|
|
Re: Financial Statement Q2, 2023 /MD&A
|
1
|
Resverlogix Corp.
|
Aug 12, 2023 01:08PM
|
|
Re: Financial Statement Q2, 2023 /MD&A
|
1
|
Resverlogix Corp.
|
Aug 13, 2023 11:39AM
|
|
Re: Financials
|
6
|
Resverlogix Corp.
|
Sep 12, 2020 12:10PM
|
|
Re: Financing
|
|
Resverlogix Corp.
|
Apr 26, 2024 11:37AM
|
